US9062066B2ActiveUtilityA1
Anti-inflammatory compound having inhibitory activity against multiple tyrosine kinases and pharmaceutical composition containing same
Est. expiryMay 26, 2030(~3.9 yrs left)· nominal 20-yr term from priority
Inventors:Beom-Seok YangYong Zu KimTae Kyo ParkSung Ho WooHyang Sook LeeSun Young KimJong Un ChoHong Bum Lee
A61P 7/06A61P 37/00A61P 43/00A61P 37/08A61P 7/00A61P 9/10A61P 37/06A61P 27/14A61P 29/00A61P 31/04A61P 27/02A61P 11/02A61P 1/04A61P 17/06A61P 25/00A61P 13/12A61P 21/04A61P 17/02A61P 1/16A61P 19/06A61P 11/06A61P 17/04A61P 11/00A61P 19/02C07D 495/04A61K 31/519
29
PatentIndex Score
0
Cited by
14
References
10
Claims
Abstract
The present invention is for the anti-inflammatory compounds that have an inhibitory activity against protein tyrosine kinases and their pharmaceutical composition(s) containing the compound as the active ingredient. Since the compounds of the present invention can inhibit multiple protein kinases associated with inflammatory diseases and immune disorders, they are useful for their prevention or treatment.
Claims
exact text as granted — not AI-modifiedThe invention claimed is:
1. A compound of the following chemical formula 1, or pharmaceutically acceptable salts thereof:
wherein,
X 1 is N or CH;
R 1 is —OH or —OCH 3 ;
Y is C 6-10 aryl substituted with R 2 , or C 5-10 heteroaryl substituted with R 2 or N-methylpiperazinyl;
R 2 is —(CH 2 ) n —R 3 , —(CH 2 ) n —C(O)—R 3 , or —O(CH 2 ) n —R 3 ;
R 3 is —H, —CN, halogen, C 1-3 alkyl, C 1-3 alkoxy, phenyl, pyridinyl, amino, C 1-3 alkyl amino, di C 1-3 alkyl amino, hydroxyl C 1-3 alkyl amino, carboxy C 1-3 alkyl amino, C 3-6 cycloalkyl C 1-3 alkylamino, pyrolidinyl, hydroxyl pyrolidinyl, hydroxyl C 1-3 alkylpyrolidinyl, carboxypyrolidinyl, piperidinyl, C 1-3 alkylpiperidinyl, di C 1-3 alkyl piperidinyl, piperazinyl, C 1-3 alkylpiperazinyl, C 1-4 alkoxycarbonylpiperazinyl, or morpholinyl; and
n is an integer selected from 0 to 3, and
wherein the compound of the chemical formula 1 is any one selected from the group consisting of—
3(6-(phenylthieno[3,2-d]pyrimidine-4-ylamino)phenol,
4-(4-(3-methoxyphenylamino)thieno[3,2-d]pyrimidine-6-yl)benzonitrile,
4-(4-(3-hydroxyphenylamino)thieno[3,2-d]pyrimidine-6-yl)benzonitrile,
4-(4-(3-methoxyphenylamino)thieno[3,2-d]pyrimidine-6-yl)phenol,
3-[6-(4-methoxyphenyl)-thieno[3,2-d]pyrimidine-4-nylamino]-phenol,
N-(3-methoxyphenyl)-6-(4-(2-morpholinoethoxy)phenyl)thieno[3,2-d]pyrimidine-4-amine,
3-(6-(4-chlorophenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(4-(2-morpholinoethoxy)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
N-(3-methoxyphenyl)-6-(4-phenethoxyphenyl)thieno[3,2-d]pyrimidine-4-amine,
N-(3-methoxyphenyl)-6-(4-(2-(pyridine-2-yl)ethoxy)phenyl)thieno[3,2-d]pyrimidine-4-amine,
(6-furan-2-yl-thieno[3,2-d]pyrimidine-4-yl)-(3-methoxyphenol)-amine,
(6-furan-3-yl-thieno[3,2-d]pyrimidine-4-yl)-(3-methoxyphenol)-amine,
N-(3-methoxyphenyl)-6-(4-(2-(pyrolidine-1-yl)ethoxy)phenyl)thieno[3,2-d]pyrimidine-4-amine,
N-(3-methoxyphenyl)-6-(thiophene-2-yl)thieno[3,2-d]pyrimidine-4-amine,
(3-methoxyphenyl)-(6-thiophene-3-yl-thieno[3,2-d]pyrimidine-4-yl)-amine,
N-(3-methoxyphenyl)-6-(4-(2-(piperazine-1-yl)ethoxy)phenyl)thieno[3,2-d]pyrimidine-4-amine,
(3-methoxyphenyl)-(6-thiophene-2-yl-thieno[3,2-d]pyrimidine-4-yl)-amine,
3-(6-thiophene-3-yl-thieno[3,2-d]pyrimidine-4-ylamino)-phenol,
3-((6-(4-(morpholinomethyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-((6-(4-(piperazine-1-ylmethyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(4-(pyrolidine-1-ylmethyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-((6-(4-(piperidine-ylmethyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-((6-(4-((4-methylpiperazine-1-yl-methyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-((6-(4-((diethylamino)methyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(furan-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(furan-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(4-((cyclopropylmethylamino)methyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-((6-(4-((isobutylamino)methyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-((6-(4-((ethylamino)methyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-((6-(4-(2-(pyrolidine-1-yl)ethyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-((6-(4-(2-(piperidine-1-yl)ethyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-((6-(4-(2-(4-methylpiperazine-1-yl)ethyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(4-(2-morpholinoethyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
2-(4-(4-(3-hydroxyphenylamino)thieno[3,2-d]pyrimidine-6-yl)phenyl)-1-(4-methylpiperazine-1-yl)ethanone,
2-(4-(4-(3-hydroxyphenylamino)thieno[3,2-d]pyrimidine-6-yl)phenyl)-1-(pyrolidine-1-yl)ethanone,
N,N-diethyl-2-(4-(4-(3-hydroxyphenylamino)thieno[3,2-d]pyrimidine-6-yl)phenyl)acetamide,
3-(4-(3-hydroxyphenylamino)thieno[3,2-d]pyrimidine-6-yl)benzoic acid,
(4-(4-(3-hydroxyphenylamino)thieno[3,2-d]pyrimidine-6-yl)phenyl)(4-methylpiperazine-1-yl)methanone,
(3-(4-(3-hydroxyphenylamino)thieno[3,2-d]pyrimidine-6-yl)phenyl(pyrolidine-1-yl)methanone,
N,N-diethyl-3-(4-(3-hydroxyphenylamino)thieno[3,2-d]pyrimidine-6-yl)benzamide,
(3-(4-(3-hydroxyphenylamino)thieno[3,2-d]pyrimidine-6-yl)phenyl(4-methylpiperazine-1-yl)methanone,
methyl 1-(4-(4-(3-hydroxyphenylamino)thieno[3,2-d]pyrimidine-6-yl)benzyl)pyrolidine-2-carboxylate,
3-(6-(4-((2-(hydroxymethyl)pyrolidine-1-yl)methyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(4-((4-methylpiperidine-1-yl)methyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(4-(((2R,6S)-2,6-dimethylpiperidine-1-yl)methyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(3-(piperidine-1-ylmethyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(3-((4-methylpiperazine-1-yl)methyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(3-(pyrolidine-1-ylmethyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(3-((diethylamino)methyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(3-(piperazine-1-ylmethyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(3-((ethylamino)methyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(3-(morpholinomethyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
1-(4-(4-(3-hydroxyphenylamino)thieno[3,2-d]pyrimidine-6-yl)benzyl)pyrolidine-2-carboxamide HCl salt,
1-(4-(4-(3-hydroxyphenylamino)thieno[3,2-d]pyrimidine-6-yl)benzyl)pyrolidine-2-carboxylic acid HCl salt,
3-(6-(4((2-hydroxyethylamino)methyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
methyl 2-(3-(4-(3-hydroxyphenylamino)thieno[3,2-d]pyrimidine-6-yl)benzamido)propanoate,
1-(4-(4-(3-hydroxyphenylamino)thieno[3,2-d]pyrimidine-6-yl)benzyl)pyrolidine-3-ol HCl salt,
3-(6-(4-(ethoxymethyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
4-(4-(3-hydroxyphenylamino)thieno[3,2-d]pyrimidine-6-yl)-N-(1-hydroxyprophane-2-yl)benzamide,
2-(4-(4-(3-hydroxyphenylamino)thieno[3,2-d]pyrimidine-6-yl)benzamido)prophane acid,
3-(6-(3-(2-(pyrolidine-1-yl)ethyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(3-(2-(piperazine-1-yl)ethyl)phenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(2-(4-(pyrolidine-1-ylmethyl)phenyl)thieno[3,2-b]pyridine-7-ylamino)phenol,
3-(6-(4-morpholinophenyl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(2-(4-(morpholinomethyl)phenyl)thieno[3,2-b]pyridine-7-ylamino)phenol,
3-(2-(4-((4-methylpiperazine-1-ylmethyl)phenyl)thieno[3,2-b]pyridine-7-ylamino)phenol,
3-(6-(5-(pyrolidine-1-ylmethyl)thiophene-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(5-(pyrolidine-1-ylmethyl)furan-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(5((4-methylpiperazine-1-yl)methyl)furan-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(5-(piperidine-1-ylmethyl)furan-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(5-(morpholinomethyl)furan-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(5-(piperazine-1-ylmethyl)furan-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(5-((ethylamino)methyl)furan-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(5-((4-methylpiperazine-1-yl)methyl)thiophene-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(5-(piperidine-1-ylmethyl)thiophene-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(5-(piperazine-1-ylmethyl)thiophene-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(5-((ethylamino)methyl)thiophene-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(2-(4-(piperidine-1-ylmethyl)phenyl)thieno[3,2-b]pyridine-7-ylamino)phenol,
3-(2-(4-(piperazine-1-ylmethyl)phenyl)thieno[3,2-b]pyridine-7-ylamino)phenol,
3-(2-(4-((ethylamino)methyl)phenyl)thieno[3,2-b]pyridine-7-ylamino)phenol,
3-(2-(4-methylpiperazine-1-yl)thiazolo[4,5-d]pyrimidine-7-ylamino)phenol,
3-(6-(4-(pyrolidine-1-ylmethyl)thiophene-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(4-((4-methylpiperazine-1-yl)methyl)thiophene-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(4-(piperidine-1-ylmethyl)thiophene-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(4-(morpholinomethyl)thiophene-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol trifluoroacetic acid)
3-(6-(4-(piperazine-1-ylmethyl)thiophene-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol trifluoroacetic acid
3-(6-(4-((ethylaminomethyl)thiophene-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(2-(3-(pyrolidine-1-ylmethyl)phenyl)thieno[3,2-b]pyridine-7-ylamino)phenol,
3-(2-(3-((4-methylpiperazine-1-yl)methyl)phenyl)thieno[3,2-b]pyridine-7-ylamino)phenol,
3-(2-(3-(piperidine-1-ylmethyl)phenyl)thieno[3,2-b]pyridine-7-ylamino)phenol,
3-(2-(3-(morpholinomethyl)phenyl)thieno[3,2-b]pyridine-7-ylamino)phenol,
3-(2-(3-(piperazine-1-ylmethyl)phenyl)thieno[3,2-b]pyridine-7-ylamino)phenol,
3-(2-(3-((ethylamino)methyl)phenyl)thieno[3,2-b]pyridine-7-ylamino)phenol,
3-(6-(4-(pyrolidine-1-ylmethyl)furan-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol,
3-(6-(4-((4-methylpiperazine-1-yl)furan-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol trifluoroacetic acid or
3-(6-(4-(piperidine-1-ylmethyl)furan-2-yl)thieno[3,2-d]pyrimidine-4-ylamino)phenol.
2. The compound according to claim 1 , wherein the compound is 3-(2-(3-(morpholinomethyl)phenyl)thieno[3,2-b]pyridine-7-ylamino)phenol.
3. The compound according to claim 1 , wherein the pharmaceutically acceptable salt is inorganic salt, organic carboxylic acid salt or sulfonic acid salt.
4. The compound according to claim 3 , wherein the inorganic salt is HCl salt and the organic carboxylic acid salt is trifluoroacetic acid salt.
5. A pharmaceutical composition for treating scar formation in wound healing process, asthma or atopic dermatitis, comprising the compound according to claim 1 as an active ingredient.
6. The pharmaceutical composition according to claim 5 , wherein the wound is characterized by trauma, burns, pressure ulcers, or one caused by diabetic foot ulcers.
7. The pharmaceutical composition according to claim 5 , wherein the pharmaceutical composition is administrated at a dose of 0.1 to 500 mg/kg body weight.
8. The pharmaceutical composition according to claim 5 , wherein the pharmaceutical composition is for dermal administration.
9. The pharmaceutical composition according to claim 5 , wherein the pharmaceutical composition is formulated as an ointment, cream or patch type.
10. A method for treating scar formation in wound healing process, asthma or atopic dermatitis, comprising the step of administering into a patient a therapeutically effective amount of the compound according to claim 1 , or pharmaceutically acceptable salts thereof.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.